The Global Bone Mineral Densitometry (BMD) Market Share is estimated to be worth US$ 310.6 Mn at a CAGR of 3.5% from 2021-2031. Advancements like the incorporation of IoT and AI in the healthcare vertical along with smart medicines and advancements in technology are expected to be the dictators of growth of the healthcare vertical in the upcoming period.
Rise in prevalence of osteoporosis in the aged population and women aged above 50 has led to a surge in demand for bone mineral densitometry. Rising awareness about osteoporosis and efforts by various foundations are increasing awareness among the women population is leading to increased demand for bone densitometers globally.
Increasing number of spinal and hip fractures requiring bone mineral density scanning to avoid re-fractures is leading to higher installation of bone mineral densitometers in healthcare settings. Osteoporosis remains highly underdiagnosed and undertreated in South East Asia and many European countries.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/32513
There has been an increase in healthcare expenditure as well as reimbursements policies among developing nations, which is creating higher demand for bone densitometers. New product launches, acquisitions, and collaborations by key players are also expected to aid market expansion.
- GE Healthcare
- Hologic, Inc.
- Beammed, Ltd.
- Swissray International, Inc.
- Osteosys Co. Ltd.
- Diagnostic Medical System SA
- Medonica Co., Ltd.
- Hitachi Ltd.
Request for Methodology @ https://www.persistencemarketresearch.com/methodology/32513
Key Takeaways from Market Study
- Axial bone densitometers hold over 68%value share, globally, as they are used for the detection of bone density in central sites, including the vertebral column, ribcage, and pelvic region.
- Dual X-ray absorptiometry (DXA) is preferred due to higher number of bone density detections at central skeletal sites as compared to peripheral.
- In terms of end user, hospitals contribute maximum share in the market due to higher footfall of patients as compared to other end-user facilities.
- North America remains dominant in the global market for bone mineral densitometers, and will continue to hold strong revenue share of more than 51%over the forecast period.
“BMD is witnessing growth in developed as well as emerging economies due to high prevalence of osteoporosis and osteoporotic fracture-related cases. Advancements in DXA technologies for higher precision and accuracy will lead a path toward improved diagnostic approaches to understand bone pathologies and preventing recurrent fractures,” says an analyst of Persistence Market Research.
Acquisitions and Collaborations – Strategy by Key Players
Key manufacturers of bone mineral densitometers are collaborating with domestic vendors to expand their channel partnerships and increase their regional and global presence.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/32513
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the bone mineral densitometry market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on the product (axial bone densitometry and peripheral bone densitometry), technology (dual-energy X-ray absorptiometry (DXA), peripheral dual energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), and others), and end user (hospitals, orthopaedic clinics, and diagnostic centers), across seven key regions of the world (North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa).
Explore Extensive Coverage of Persistence Market Research’s Healthcare Industry
Neurostimulation Devices Market:
The global neurostimulation devices market is poised to grow at double-digit CAGR by the end of 2025. The growing awareness regarding mental health acts as a primary growth factor. Technological innovations implementing better patient management are expected to drive growth in the market. Novel technologies for restoring vision and aiding movement in paralysis are projected to escalate the adoption rate of these devices in the market.
According to a new market report published by Persistence Market Research “Global Market Study on Biopharmaceuticals: Asia to Witness Highest Growth by 2020”, the global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to grow at a CAGR of 9.4% from 2014 to 2020, to reach an estimated value of US$ 278 Bn by 2020.
Infectious Diseases Diagnostics Market:
The global infectious diseases diagnostics market is predicted to expand at a CAGR of 7.0% over an eight-year forecast period, 2016-2024. The market will reach a value worth US$ 876.6 Mn by 2016 end, up from US$ 827.7 Mn attained in 2015. The revenues are expected to reach US$ 1503.8 Mn by the end of 2024.
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com